Kikuchi Disease: Symptoms, Causes, and the Lupus Connection

Kikuchi disease, formally called Kikuchi-Fujimoto disease, is a rare, benign condition in which lymph nodes become inflamed and partially destroyed by the body’s own immune cells. It typically shows up as tender, swollen lymph nodes in the neck, often with fever, and resolves on its own within a few weeks to months.¹ The condition is not well known outside of pathology and rheumatology circles, and getting diagnosed often involves ruling out far more dangerous possibilities, including lymphoma and lupus. That diagnostic journey, along with the anxiety it provokes, is a central part of the Kikuchi experience.

Who Gets Kikuchi Disease

Kikuchi disease was first described independently by two Japanese pathologists in 1972. It was initially thought to affect almost exclusively young Asian women, but case reports from around the world have broadened that picture. A review of 244 cases found that about three-quarters of patients were female, the average age was 25, and roughly 70% were younger than 30. While the largest share of reported cases came from Taiwan, the condition has been documented across North America, Europe, the Middle East, and elsewhere.² A study from the Eastern Mediterranean region confirmed the pattern, with a mean patient age of 32 and women making up about 73% of cases.³

The sex ratio is not entirely straightforward, though. A large clinicopathological study found that among patients in their twenties and younger, men actually outnumbered women. Female predominance became clear in patients in their thirties and older.⁴ So the widely repeated claim that Kikuchi disease overwhelmingly affects young women is a simplification. Young men get it too, and cases have been documented in children as young as four and in adults into their sixties.

The Unknown Cause

Despite decades of research, nobody has pinned down what triggers Kikuchi disease. The leading hypothesis is that some kind of infection sets off an exaggerated immune response in genetically susceptible people, but the specific infectious agent remains elusive. Early attention focused on Epstein-Barr virus (EBV) and human herpesvirus 6 (HHV-6) because the clinical features looked like they could be viral. One investigation found that EBV appeared in only a fraction of Kikuchi cases and that HHV-6 played no role, concluding that neither virus could be implicated as a cause.⁵

A subsequent study expanded the viral search to include parvovirus B19 and HHV-8, using molecular testing on lymph node tissue. It found no significant difference in the prevalence of EBV, HHV-6, HHV-8, or parvovirus B19 between Kikuchi patients and controls, and concluded that none of these viruses appeared to drive the disease.⁶ Interestingly, a different study did commonly detect EBV DNA in Kikuchi lymph nodes, raising the possibility that in some cases the tissue damage is a vigorous immune reaction against EBV-infected cells rather than a direct viral infection of the node.⁷ The research, in other words, points in different directions. The honest summary is that we do not yet know the cause, though some kind of immune overreaction in a person with the right genetic makeup remains the best working theory.

The genetic angle is suggestive but thin. Certain tissue types (HLA alleles) have been associated with the disease, and there is at least one documented case of two non-twin sisters with identical HLA types both developing Kikuchi disease a decade apart.⁸ Familial cases are rare, but they reinforce the idea that host genetics matter.

What Happens Inside the Lymph Node

The hallmark of Kikuchi disease is what pathologists call necrotizing lymphadenitis: patches of cell death within the lymph node surrounded by a specific cast of immune cells. Diagnosis requires a lymph node biopsy, and the microscopic features are distinctive enough to be diagnostic when read by a pathologist who recognizes them. The characteristic picture includes areas of cell death with abundant nuclear debris, a proliferation of histiocytes (tissue-cleaning cells) and plasmacytoid dendritic cells, and an influx of CD8-positive T cells, all without the neutrophils you would expect in a typical bacterial infection.⁹

The cell death appears to be driven by apoptosis, an orderly form of programmed cell death rather than the messy destruction caused by infection. Studies have shown that the dead cells in Kikuchi lymph nodes carry markers of the Fas-Fas ligand pathway, a well-known trigger for apoptosis.¹⁰ Meanwhile, plasmacytoid dendritic cells cluster densely around the zones of cell death, and the CD8-positive T cells that fill the node are cytotoxic, meaning they are armed to kill. These T cells also infiltrate the lymphoid follicles, distorting the node’s internal architecture.¹¹ The overall picture suggests the immune system is waging a highly targeted attack within the lymph node, though against what target remains unclear.

Symptoms and How Kikuchi Presents

The most common complaint is a tender, swollen lymph node on one side of the neck. In a large pediatric study, cervical lymph node enlargement was present in over 97% of patients, and fever occurred in 85%, with most of those fevers reaching at least 39°C (about 102°F). Prolonged fever lasting two weeks or more was seen in about 44% of cases.¹² Night sweats, fatigue, and weight loss can also occur, which adds to the worry that something more serious is going on.

Skin changes occur in a subset of patients. The specific rashes associated with Kikuchi disease have not been thoroughly catalogued, but a detailed review of 16 patients with cutaneous involvement confirmed that skin manifestations do accompany the lymphadenopathy in some people.¹³ These can include facial rashes, nonspecific red patches, and papules, features that sometimes lead clinicians to suspect lupus before Kikuchi is confirmed.

Blood work tends to show a low white blood cell count. In one pediatric cohort, about 73% of patients had leukopenia, and none had an elevated white count.¹⁴ Inflammatory markers are usually modestly elevated rather than sky-high, which is another clue: a wildly high CRP or ESR should make the clinician think harder about other diagnoses. Anemia and low platelet counts can also appear, particularly in children.¹⁵

Why It Gets Mistaken for Lymphoma

For most patients, the scariest part of Kikuchi disease is not the disease itself but the diagnostic process. A young person with a large, tender neck mass, fever, night sweats, and low blood counts raises an immediate red flag for lymphoma. Imaging studies do not always help settle the question. On CT scans, Kikuchi lymph nodes average about 1.6 cm and most commonly show homogeneous enhancement, with perinodal infiltration visible in roughly 80% of patients.¹⁶ PET/CT scans, which detect metabolically active tissue, can light up dramatically in Kikuchi disease. One pediatric study found that the metabolic activity in Kikuchi nodes overlapped significantly with lymphoma and was statistically indistinguishable from it based on the imaging signal alone. The key differentiator was that Kikuchi cases showed uptake only in lymph nodes, while lymphoma patients often had uptake in other organs like bone marrow or the spleen.¹⁷

Even under the microscope, the distinction can be tricky. Kikuchi nodes sometimes contain sheets of large, rapidly dividing T cells that look alarming to a pathologist. A study of 25 such cases found that these large cells were CD8-positive cytotoxic T cells with a high growth rate, and in a significant minority, molecular testing even detected clonal gene rearrangements, a finding that ordinarily suggests lymphoma. The features that pointed toward Kikuchi and away from lymphoma included the fact that the lymph node architecture was only partially disrupted, and that the background contained the hallmark karyorrhectic debris and plasmacytoid dendritic cell clusters.¹⁸ Getting this distinction right matters enormously, because the treatment for lymphoma is chemotherapy, and misdiagnosis would expose a patient with a self-limiting condition to unnecessary and potentially harmful therapy.

A diagnostic scoring system has been proposed to help clinicians distinguish Kikuchi from lymphoma using a combination of clinical features and imaging. Factors favoring Kikuchi include younger age (under about 35), the presence of fever and joint pain, abnormal white cell count, and the absence of lymph node clumping. This scoring system achieved high accuracy in the study that developed it, but it has not yet been widely validated.¹⁹ In practice, the gold standard remains a full lymph node biopsy read by an experienced pathologist.

The Lupus Connection

Kikuchi disease and systemic lupus erythematosus share overlapping features to a degree that creates real diagnostic confusion. Both can cause fever, lymphadenopathy, skin rash, low white cell counts, and even similar-looking changes under the microscope. A systematic review of the clinical association between the two conditions found that among patients who had both diagnoses, lupus was already known in only 18% of cases at the time Kikuchi was diagnosed. In just over half, both conditions were identified at the same time, and in about 31% of cases, lupus developed after Kikuchi.²⁰

This means that a Kikuchi diagnosis should prompt ongoing monitoring for lupus, especially in young women. In a follow-up study of patients with recurrent Kikuchi disease, five out of fourteen who relapsed went on to develop autoimmune disease, including lupus, Graves’ disease, and mixed connective tissue disease.²¹ Whether Kikuchi is an early manifestation of lupus, a related immune phenomenon, or simply a look-alike remains an open question. But the practical takeaway is clear: people diagnosed with Kikuchi should have autoimmune screening and should not vanish from follow-up after the lymph nodes shrink.

Treatment and Recovery

There is no specific treatment for Kikuchi disease. The condition is self-limiting, with most cases resolving within one to six months.²² For most people, treatment is supportive: anti-inflammatory pain relievers for discomfort and fever, rest, and reassurance. In a pediatric cohort, about 60% of cases followed a fully self-limited course without any prescription treatment.²³

When symptoms are severe or prolonged, corticosteroids are commonly used. In a retrospective study of 91 patients, steroids were prescribed in about a third of cases, hydroxychloroquine in roughly 18%, and intravenous immunoglobulin in a small number. The disease course was favorable in all cases.²⁴ Steroids are not universally needed, and some patients relapse when steroids are tapered. One case required a prolonged steroid course of seven months due to symptom recurrence every time the dose was reduced.²⁵ Antibiotics are sometimes given early on before the diagnosis is established, but they do not help Kikuchi disease and should be stopped once the condition is confirmed.

Recurrence

While most patients recover fully and never deal with Kikuchi disease again, recurrence is not as rare as many patients are told. Estimates range widely, from about 3% to over 40%, depending on the study population and how long patients were tracked.²⁶ In one cohort where patients were followed for at least six months, about 15% had a recurrence, and those who relapsed were more likely to eventually develop an autoimmune condition.²⁷ In a pediatric study, about 10.5% of children had a recurrence, with a median gap of about 19 months between episodes.²⁸

A recurrence does not mean the prognosis has changed. Each episode still follows the same self-limiting pattern. But recurrence should raise the index of suspicion for an underlying autoimmune condition and prompt appropriate testing. Given all this, long-term follow-up after a Kikuchi diagnosis is warranted even when the initial episode resolves completely.

Rare but Serious Complications

Kikuchi disease is overwhelmingly benign, but there are uncommon complications worth knowing about. The most discussed is hemophagocytic lymphohistiocytosis (HLH), a life-threatening syndrome in which the immune system goes into overdrive and begins destroying the body’s own blood cells. Because Kikuchi itself involves an intense immune response, it may in rare cases escalate into HLH.²⁹ The two conditions share enough clinical overlap that some researchers have suggested they may sit on the same spectrum rather than being separate entities. When Kikuchi is complicated by HLH, it can lead to clotting problems and organ failure, making early recognition critical.³⁰ Warning signs include persistent high fevers that do not respond to treatment, an enlarging liver or spleen, dropping blood counts across all cell lines, and very high ferritin levels.

Neurological involvement is another uncommon complication. Kikuchi can occasionally affect the central nervous system, presenting as aseptic meningitis or encephalitis. In two documented cases, a teenager developed meningitis with extremely high intracranial pressure, and a young man presented with abnormal sensations in one leg along with brain imaging abnormalities. In both cases, the characteristic cervical lymphadenopathy appeared only after the neurological symptoms, making early diagnosis particularly difficult. Both patients improved with steroid treatment.³¹ These neurological presentations are rare enough that they show up mostly as isolated case reports, but they illustrate why persistent or atypical symptoms in someone with Kikuchi disease should be taken seriously.

Kikuchi Disease in Children

Children can and do get Kikuchi disease, and the presentation overlaps considerably with the adult version: fever, tender neck nodes, and sometimes a rash. The challenge in pediatric cases is that the same constellation of symptoms can suggest infections, autoimmune conditions, or childhood cancers, and the workup can be prolonged and frightening for families. The most common presentations in children are prolonged fever, tender cervical lymphadenopathy, and skin rash, along with low white cell counts and elevated inflammatory markers.³²

Blood tests and imaging studies are not definitive in children any more than in adults, and the diagnosis ultimately rests on biopsy. An important practical point: antibiotics were initially prescribed in about 20% of pediatric cases before the correct diagnosis was established, and corticosteroids were used in about 40%, often in children with oral ulcers or anemia.³³ Parents should know that while the disease is alarming to go through, the prognosis for children is the same as for adults: favorable, self-limiting, and rarely complicated. The key is awareness. When clinicians consider Kikuchi early in the differential, it can spare families from extended rounds of unnecessary testing and ineffective treatments.

COVID-19 Vaccination and Kikuchi Disease

A small number of case reports have described Kikuchi disease arising after COVID-19 vaccination, sometimes complicated by aseptic meningitis.³⁴ It is worth putting this into perspective. Case reports document temporal associations, not causation, and given the billions of vaccine doses administered worldwide, a handful of Kikuchi cases afterward does not rise above what you might expect by coincidence. The finding is consistent with the broader theory that Kikuchi disease can be triggered by immune stimulation of various kinds, whether from an infection, a vaccine, or something else entirely. It is not a reason to avoid vaccination, but it is a diagnosis worth considering in someone who develops unexplained lymphadenopathy and fever in the weeks following any vaccine.